Quantcast
Last updated on April 16, 2014 at 4:43 EDT

Latest Neuraminidase inhibitors Stories

2011-01-12 14:44:05

Tom Jefferson and colleagues from the Cochrane Group argue that the current system for assessing the safety and effectiveness of drugs, based on published trial data only, is "wholly inadequate" and "ethically dubious." They propose a new approach that would allow in-depth scrutiny of the complete set of trial data for a new drug. Their call comes after they reviewed the evidence for the antiviral drug oseltamivir (Tamiflu), and were unable to find sufficient published data to support the...

2010-12-15 15:25:30

Study published in PLoS ONE Carrageenan, is a polymer derived from red seaweed which helps to create a protective physical barrier in the nasal cavity and has proven to be an effective antiviral in the treatment of the common cold. The present study assessed the efficacy of Carrageenan against influenza viruses, including the pandemic H1N1 influenza strain. Results showed that the polymer directly binds to influenza viruses, effectively blocking the virus from attaching to cells and spreading...

2010-12-07 22:35:24

Studies highlight need for new antiviral treatment options and strategies Two new studies raise public health concerns about increasing antiviral resistance among certain influenza viruses, their ability to spread, and a lack of alternative antiviral treatment options. The findings are published in the January 1 issue of The Journal of Infectious Diseases. (Please see below for links to these articles online.) Influenza viruses are treated with two classes of drugs: M2 blockers (adamantanes)...

2010-11-04 08:24:30

(Ivanhoe Newswire) -- In adults with seasonal influenza A virus infection, the combination of the drugs oseltamivir (tamiflu) and zanamivir (relenza) is less effective than oseltamivir monotherapy and not significantly more effective than zanamivir monotherapy. In the past few years oseltamivir and zanamivir have been key drugs for limiting the impact of seasonal influenza both in individuals (by reducing morbidity and mortality) and collectively (by slowing the virus' spread to buy time for...

2010-11-04 01:05:46

In adults with seasonal influenza A virus infection, the combination of the drugs oseltamivir (tamiflu) and zanamivir (relenza) is less effective than oseltamivir monotherapy and not significantly more effective than zanamivir monotherapy. This key finding comes from a randomized, placebo-controlled trial"” in adults presenting with influenza symptoms at general practices throughout France during the seasonal influenza epidemic in 2008-2009"” carried out by Catherine Leport from...

2010-10-21 11:24:00

LOURES, Portugal, October 21, 2010 /PRNewswire/ -- Hovione has been advised by Daiichi Sankyo Company Ltd that Inavir(R) has been launched in Japan. Inavir(R) is an inhalation powder which is delivered by the TwinCaps(R) inhaler to treat influenza. TwinCaps(R) was specifically designed by Hovione for this indication and is licensed to Daiichi Sankyo and to Biota Holdings Ltd. Daiichi Sankyo has demonstrated that one 40mg dose of Inavir(R) active ingredient, laninamivir...

2010-09-29 13:48:58

Research: Effectiveness of oseltamivir on disease progression and viral RNA shedding in patients with mild pandemic 2009 influenza A H1N1: opportunistic retrospective study of medical charts in China Healthy people who caught swine flu during the 2009 pandemic may have been protected against developing radiographically (x-ray) confirmed pneumonia by taking the antiviral drug oseltamivir (Tamiflu), concludes a study of cases in China published on bmj.com today. The researchers also show that...

2010-07-26 15:01:00

SAN DIEGO, July 26 /PRNewswire-FirstCall/ -- Gen-Probe Incorporated (Nasdaq: GPRO) announced today that the U.S. Food and Drug Administration (FDA) has cleared for marketing Prodesse's ProFAST(TM)+ assay, making it the only FDA-cleared molecular diagnostic test to simultaneously detect and differentiate three common influenza A virus subtypes - seasonal A/H1, seasonal A/H3, and 2009 H1N1. "FDA clearance of our ProFAST+ assay is important for public health, as the test enables physicians to...

0096d0aa4236521eb82f2c43eaa20af81
2010-06-22 10:24:12

Fraudulent product is dangerous to patients allergic to penicillin The U.S. Food and Drug Administration today warned consumers about a potentially harmful product represented as "Generic Tamiflu" sold over the Internet. FDA tests revealed that the fraudulent product does not contain Tamiflu's active ingredient, oseltamivir, but cloxacillin, an ingredient in the same class of antibiotics as penicillin. The agency reminds patients who are allergic to or may have experienced adverse reactions...

2010-06-17 14:00:00

Fraudulent product is dangerous to patients allergic to penicillin SILVER SPRING, Md., June 17 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today warned consumers about a potentially harmful product represented as "Generic Tamiflu" sold over the Internet. FDA tests revealed that the fraudulent product does not contain Tamiflu's active ingredient, oseltamivir, but cloxacillin, an ingredient in the same class of antibiotics as penicillin. (Logo:...